Imbria Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Imbria Pharmaceuticals has a total of 96 patents globally, out of which 14 have been granted. Of these 96 patents, more than 71% patents are active. The United States of America is where Imbria Pharmaceuticals has filed the maximum number of patents, followed by Europe and Israel. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Imbria Pharmaceuticals.

Imbria Pharmaceuticals was founded in 2018. Imbria Pharmaceuticals is a clinical stage, privately held company creating innovative treatments for individuals with serious cardiometabolic illnesses. The clinical stage pipeline of the company is focused on repairing or increasing the cell’s ability to create energy in cardiovascular illnesses where energetic impairment is a significant contributor to symptoms and functional deficiencies.

Do read about some of the most popular patents of Imbria Pharmaceuticals which have been covered by us in this article and also you can find Imbria Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Imbria Pharmaceuticals patent portfolio.

How many patents does Imbria Pharmaceuticals have?

Imbria Pharmaceuticals has a total of 96 patents globally. These patents belong to 20 unique patent families. Out of 96 patents, 69 patents are active.

How Many Patents did Imbria Pharmaceuticals File Every Year?

Imbria Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantImbria Pharmaceuticals Applications FiledImbria Pharmaceuticals Patents Granted
202314
202296
2021322
2020132
201920
201819
20172

How many Imbria Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Imbria Pharmaceuticals Patent Portfolio

How Many Patents did Imbria Pharmaceuticals File in Different Countries?

Imbria Pharmaceuticals Worldwide Patent Filing

Countries in which Imbria Pharmaceuticals Filed Patents

CountryPatents
United States Of America29
Europe12
Israel8
Australia7
Korea (South)7
China7
Canada7
Poland1
Italy1
Austria1
Spain1

Where are Research Centers of Imbria Pharmaceuticals Patents Located?

R&D Centres of Imbria Pharmaceuticals

10 Best Imbria Pharmaceuticals Patents

US10556013B2 is the most popular patent in the Imbria Pharmaceuticals portfolio and it has received 14 citations.

Below is the list of 10 most cited patents of Imbria Pharmaceuticals:

Publication NumberCitation Count
US10556013B214
US20190216936A18
WO2020081361A18
US10918728B24
US20210353617A14
WO2020243119A14
US11376330B22
US10953102B22
WO2020247213A12
US20220249463A11

What Percentage of Imbria Pharmaceuticals US Patent Applications Were Granted?

Imbria Pharmaceuticals (Excluding its subsidiaries) has filed 29 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 85.71%.

Below are the key stats of Imbria Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Imbria Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Brown Rudnick Llp2985.71%

What are Imbria Pharmaceuticals key innovation segments?

What Technologies are Covered by Imbria Pharmaceuticals?

The chart below distributes patents filed by Imbria Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Imbria Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Imbria Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Imbria Pharmaceuticals?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.